Source: Fox News
Summary
Researchers from Kumamoto University in Japan have developed an oral insulin pill that could potentially replace injections for people with diabetes. The pill uses a carrier peptide called DNP-V to transport insulin through the small intestine, where protein absorption is typically poor. In diabetic mice models, the treatment resulted in a rapid and significant drop in blood glucose levels. The study’s findings suggest that DNP peptides could serve as a platform for delivering large-molecule drugs orally.
Our Reading
The advice sounds familiar.
Oral insulin has been in the works for years, with various studies and trials attempting to find a non-invasive treatment option. This latest development is just another phase in the ongoing quest for a pill that can replace injections. The use of DNP-V as a carrier peptide is a promising step forward, but as with any new treatment, more research is needed to ensure its safety and efficacy in humans. The potential benefits of oral insulin are clear, but the journey to get there is often long and winding. As Dr. Marc Siegel noted, “This is very promising provided that it works in humans, which is a big ‘if.'”
Author: Evan Null
